Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lymphomas B-cell With Multiple or Recurrent Lesions

NCT02867553 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT02867553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02867553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lymphomas B-cell With Multiple or Recurrent Lesions
Lead sponsor
CHU de Reims
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2011
Completion date
January 31, 2019
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

indolent cutaneous b cell lymphomas